NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

I agree with you austinmediainc. I do not believe a halt will not cause it to jump to a $6 Billion valuation. It will cause NWBO's PPS to jump, but $6 Billion valuation might be too rich for that.

Germany HE will. Because it provides an initial glimpse of what the potential market is once approval is granted AND what kind of demand is on the backend. That # of Patients on the waiting list is the biggie. Pent-up demand causes true PPS gains.

- The # of patients waiting (potential demand)
- Re-imbursement price from Germany (potential pricing + premium)
- # of Hospitals participating in HE (available supply)

are all real life indicators of potential financial success of NWBO's DCVax-L product after approval. I am confident in the science, but there are a lot of other biotechs that have great science as well. But it is this new avenue that made me invest.

This is the unique factor about NWBO that no other BioTech has. This makes modeling future success easier and more believable then some SWAG market penetration % + patient's willingness to sign up + hypothetical pricing + whatever other assumptions folks come up with to justify their future PPS predictions.